<DOC>
	<DOC>NCT01422941</DOC>
	<brief_summary>The objectives of this clinical research project are to demonstrate the safety and feasibility of CAVU Medical, Inc.'s Attune Device.</brief_summary>
	<brief_title>Safety and Performance of the CAVU Medical, Inc. Attune Tubing Study</brief_title>
	<detailed_description />
	<criteria>1. The subject is at least 18 years of age. 2. The subject has been informed of the nature of the trial and agrees to its provisions. 3. The subject has a preimplantation BMI within the protocol limits. 4. The subject agrees to the followup visit schedule. 5. The subject is a candidate for a LAGB procedure. 6. The subject agrees to comply with specified followup evaluations. 7. The subject is willing to fast for 2 hours prior to each adjustment visit. 1. The subject is pregnant or is not willing to use an effective method of birth control for the duration of the trial. 2. The subject has a condition that is contraindicated for LAGB procedures. 3. The subject is currently using weight loss medications or supplements. 4. The subject has a concurrent terminal medical condition with a life expectancy of less than 12 months. 5. The subject is currently participating in an investigational drug or another medical device trial. 6. The subject had a previous LAGB procedure. 7. The Investigator believes that the patient has physical or mental conditions that would render trial participation inappropriate.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>